Category Archives: Cardiac Regeneration

Rapid advancements in stem cell research, development of novel stem cell technology, use of stem cell therapy to treat chronic and rare diseases, and rapid progress of regenerative medicine are some key factors expected to drive market growth NEW YORK, Jan. 10, 2022 /PRNewswire/ -- Reports and Data has published its latest report titled "Stem Cells Market By Product (Adult Stem Cells, Human Embryonic Stem Cells, IPS Cells, and Very Small Embryonic-Like Stem Cells), By Technology (Cell Acquisition, Cell Production, Cryopreservation, and Expansion & Sub-Culture), By Therapies (Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy), and By Application (Regenerative Medicine and Drug Discovery & Discovery), and By Region Forecast To 2028." Reports and Data Logo According to the latest report by Reports and Data, the global stem cells market size was USD 10.13 billion in 2020 and is expected to reach USD 19.31 Billion in 2028 and register a revenue CAGR of 8.4% during the forecast period, 2021-2028. Request a Sample Report https://www.reportsanddata.com/sample-enquiry-form/2981 Drivers, Restraints, & Opportunities Stem cells are cells that have the potential to differentiate into different types of cells in the body Continue reading →

An army of digital health technologies like Artificial Intelligence (AI)-powered gadgets like digital stethoscope, electronic tattoos which monitor vitals, miniscule sensors, and smartwatches tracking heartbeats are quickly transforming the traditional preventive tools of Cardiovascular Disease (CVDs). Experts pronounce that digital platforms like augmented reality will break the barriers and change the scenario of cardiac care Continue reading →

This article was originally published here J Clin Invest. 2021 Oct 1;131(19):e138637 Continue reading →

A genetic syndrome that affects bones Osteogenesis Imperfecta (OI) is a hereditary disorder occurring in 1:10,000 births and characterised by osteopenia (bone loss) and skeletal fragility (fractures). Secondary features include short stature, skeletal deformities, blue sclera and dentinogenesis imperfect. (1) There is a large clinical variability in OI, and severity ranges from mild to lethal, based on radiological characteristics Continue reading →

Wireless, battery-free, fully implantable pacemakers made of bioresorbable components could represent the future of temporary pacing technology. Continue reading →

Researchers at Northwestern and George Washington (GW) universities have developed the first-ever transient pacemaker, a wireless, battery-free, fully implantable pacing device that disappears after its no longer needed. Continue reading →

Myocardial revascularization is an alternate procedure for patients suffering from ischemic heart disease and who cannot undergo interventions like heart bypass surgery due to widespread coronary artery disease, procedure failure, small coronary arteries, or cardiac stenosis. Further, reparative stem cells can restore the function of damaged tissue by renewing cell growth in cardiac cells destroyed by heart disease. The key players profiled in the Myocardial Revascularization, Repair, And Regeneration Products And Therapies Market research study includes: Request Sample Copy of Myocardial Revascularization, Repair, And Regeneration Products And Therapies Market research report at Link https://www.theinsightpartners.com/sample/TIPRE00021590/ Since, the key findings in the Myocardial Revascularization, Repair, And Regeneration Products And Therapies Market research reports highlight crucial progressive industry trends, it allows the companies across the value chain to develop effective long-term strategies. Continue reading →

Regenerative medicine is a part of translational research in the fields of molecular biology and tissue engineering. This type of medicine involves replacing and regenerating human cells, organs, and tissues with the help of specific processes Continue reading →

The rising geriatric population and the increasing prevalence of nerve injuries are driving the demand of the market. Continue reading →

PHOENIX, Dec. 10, 2020 /PRNewswire/ --Creative Medical Technology Holdings trading under the ticker symbol CELZ announced today its patent filing based on data covering utilization of the Company's ImmCelz product at generating what is termed in the field of immunology as "infectious tolerance." Using an animal model of rheumatoid arthritis, investigators demonstrated administration of ImmCel protected mice from immunologically mediated joint damage. Continue reading →